SM
Semler Scientific, Inc.
SMLR · NASDAQ
$21.00 +18.09% (+$3.22)
Market Cap $269.6M
P/E Ratio 6.40x
Div. Yield -
ROE 15.65%
Bulios Fair Price
$30.23
44.0% upside
Current Price
$21
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SMLR is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
82 /100
Cheap P/S 7.30x
P/B 0.59x
PEG 0.04x
Growth
67 /100
Growing Rev. growth 20.05%
FCF growth 11.53%
Book val. growth 62.09%
Profitability
40 /100
Moderate Net margin 130.80%
Op. margin 94.71%
FCF margin 1,051.92%
Quality
34 /100
Average ROE 15.65%
ROA 8.10%
Asset turnover 0.06x
Debt
80 /100
Low Current ratio 1.97x
Int. coverage -12.85x
Net debt/EBITDA -2.28x
Stability
75 /100
Stable Rev. volatility 15.44%
EPS volatility 19.68%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SMLR
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Douglas Murphy-Chutorian
Employees
79
Headquarters
Santa Clara